U.S. markets open in 1 hour 46 minutes

Enlivex Therapeutics Ltd. (ENLV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.7100-0.0600 (-3.39%)
At close: 03:59PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 12/8/2023
Market Cap (intraday)
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (5 yr expected)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 3-60.32%
S&P500 52-Week Change 316.55%
52 Week High 34.6500
52 Week Low 31.2700
50-Day Moving Average 31.6016
200-Day Moving Average 32.4741

Share Statistics

Avg Vol (3 month) 331.45k
Avg Vol (10 day) 314.04k
Shares Outstanding 518.6M
Implied Shares Outstanding 618.6M
Float 814.51M
% Held by Insiders 111.83%
% Held by Institutions 19.78%
Shares Short (Nov 14, 2023) 4111.1k
Short Ratio (Nov 14, 2023) 42.88
Short % of Float (Nov 14, 2023) 40.64%
Short % of Shares Outstanding (Nov 14, 2023) 40.60%
Shares Short (prior month Oct 12, 2023) 4104.74k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 05, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3Mar 05, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Sep 29, 2023


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-28.18%
Return on Equity (ttm)-53.23%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -26.05M
Net Income Avi to Common (ttm)-27.16M
Diluted EPS (ttm)-1.4700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)30.5M
Total Cash Per Share (mrq)1.64
Total Debt (mrq)4.52M
Total Debt/Equity (mrq)11.65%
Current Ratio (mrq)7.34
Book Value Per Share (mrq)2.09

Cash Flow Statement

Operating Cash Flow (ttm)-23.06M
Levered Free Cash Flow (ttm)-16.47M